Rabies: Epidemiological tendencies and control tools

Developments in Biologicals

Volumn 125, Issue , 2006, Pages 3-13

  Tordo, N ^a   Bahloul, C ^b   Jacob, Y ^a   Jallet, C ^a   Perrin, P ^a   Badrane, H ^c  

^a INSTITUT PASTEUR   (France)

^b PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Lyssavirus; Rabies

Indexed keywords

DNA VACCINE; EPITOPE; RABIES VACCINE;

ANIMAL; CONFERENCE PAPER; DISEASE CARRIER; DISEASE TRANSMISSION; HUMAN; IMMUNOLOGY; MORTALITY; RABIES; RABIES VIRUS; VIRUS ENCEPHALITIS;

ANIMALS; DISEASE VECTORS; ENCEPHALITIS, VIRAL; EPITOPES; HUMANS; LYSSAVIRUS; RABIES; RABIES VACCINES; VACCINES, DNA;

EID: 33745550101     PISSN: 14246074     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (51)

1. Knobel D, Cleaveland S, Coleman PG, Fèvre EM, Meltzer MI, Miranda MEG, Shaw A, Zinsstag J, Meslin FX : Re-evaluating the burden of rabies in Africa and Asia. Bull WHO 2005; 83: 360-368.
2. Belotto A, Leanes LF, Schneider MC, Tamayo H, Correa E: Overview of rabies in the Americas. Virus Res 2005; 111: 5-12.
3. Tordo N, Benmansour A, Calisher C, Dietzgen RG, Fang R-X Jackson AO, Kurath G, Nadin-Davis S, Tesh RB, Walker, PJ: Rhabdoviridae, in Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball A (eds): Virus Taxonomy, VIIIth Report of the ICTV. London, Elsevier/Academic Press, 2005, pp 623-644.
4. Willoughby RE, Tieves KS, Hoffman GM, Ghanayem NS, Amlie-Lefond CM, Schwabe MJ, Chusid MJ, Rupprecht CE: Survival after Treatment of Rabies with Induction of Coma. N Engl J Med 2005; 352: 2508-2514.
5. Lafon M: Rabies virus receptors. J Neurovirol 2005; 11: 82-87.
6. Tordo N, Ceccaldi PE, Gaudin Y, Wandeler A: Rhabdovirus: Rabies, in Collier L, Many B (eds): Topley & Wilson's Microbiology and Microbial Infections (10th ed). London, Hodder Arnold, 2005, pp 1102-1136.
7. Finke S, Conzelmann KK: Replication strategies of rabies virus. Virus Res 2005; 111: 120-131.
8. Raux H, Flamand A, Blondel D: Interaction of the rabies P protein with the LC8 dynein light chain. J Virol 2000; 74: 10212-10216.
9. Jacob Y, Badrane H, Ceccaldi PE, Tordo N: Cytoplasmic dynein LC8 interacts with lyssavirus phosphoprotein. J Virol 2000; 74: 10217-10222.
10. Bourhy H, Kissi B, Badrane H, Tordo N: Molecular diversity of the Lyssavirus genus. Virology 1993; 194: 70-81.
11. Badrane H, Bahloul C, Perrin P, Tordo N: Evidence of two lyssavirus phylogroups with distinct pathogenicity and immunogenicity. J Virol 2001; 75: 3268-3276.
12. Nadin-Davis SA, Abdel-Malik M, Armstrong J, Wandeler AI: Lyssavirus P gene characterisation provides insights into the phylogeny of the genus and identifies structural similarities and diversity within the encoded phosphoprotein. Virology 2002; 298: 286-305.
13. Kuzmin IV, Orciari LA, Arai YT, Smith JS, Hanlon CA, Kameoka Y, Rupprecht CE: Bat lyssaviruses (Aravan and Khujand) from Central Asia: phylogenetic relationships according to N, P and G gene sequences. Virus Res 2003; 97: 65-79.
14. Kuzmin IV, Hughes GJ, Botvinkin AD, Orciari LA, Rupprecht CE: Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantitative criteria based on the N gene sequence for lyssavirus genotype definition. Virus Res 2005; 111: 28-43.
15. Arguin PM, Murray-Lillibridge K, Miranda MEG, Smith JS, Calaor AB, Rupprecht CE: Serologic evidence of Lyssavirus infections among bats, the Philippines. Emerg Infect Dis 2002; 8: 258-262.
16. Reynes J-M, Molia S, Audry L, Hout S, Ngin S, Walston J, Bourhy H: Serologic evidence of Lyssavirus infection in bats, Cambodia, Emerg Infect Dis 2004; 10: 2231-2234.
17. Lumlertdacha B, Boongird K, Wanghongsa S, Wacharapluesadee S, Chanhome L, Khawplod P, Hemachudha T, Kuzmin I, Rupprecht CE: Survey of bat lyssaviruess, Thailand. Emerg Infect Dis 2005; 11: 232-236.
18. Smith JS, Orciari LA, Yager PA, Seidel HD, Warner CK: Epidemiologic and historical relationships among 97 rabies virus isolates as determined by limited sequence analysis. J Infect Dis 1992; 16: 296-307.
19. Badrane H, Tordo N: Host-switching in lyssavirus history from chiroptera to carnivora orders. J Virol 2001; 75: 8096-8104.
20. Holmes EC, Woelk CH, Kassis R, Bourhy H: Genetic constraints and the adaptative evolution of rabies virus in nature. Virology 2002; 292: 247-257.
21. Hughes GJ, Orciari LA, Rupprecht CE: Evolutionary timescale of rabies virus adaptation to North American bats inferred from the substitution rate of the nucleoprotein gene. J Gen Virol 2005; 86: 1467-1474.
22. Velasco-Villa A, Orciari LA, Souza V, Juarez-Islas V, Gomez-Sierra M, Castillo A, Flisser A, Rupprecht CE: Molecular epizootiology of rabies associated with terrestrial carnivores in Mexico. Virus Res 2005; 111: 13-27.
23. Fooks AR, Brookes SM, Johnson N, McElhinney LM, Hutson AM: European bat lyssaviruses: an emerging zoonosis. Epidemiol Infect 2003; 131: 1029-1039.
24. Muller T, Cox J, Peter W, Schafer R, Johnson N, McElhinney LM, Geue JL, Tjornehoj K, Fooks AR: Spill-over of European bat lyssavirus type 1 into a stone marten (Martes foina) in Germany. J Vet Med B Infect Dis Vet Public Health 2004; 51: 49-54.
25. Daoust PY, Wandeler AI, Casey GA: Cluster of rabies cases of probable bat origin among red foxes in Prince Edward Island, Canada. J Wildl Dis 1996; 32: 403-406.
26. th RITA Conference, Peterborough, Canada: 47.
27. Vos A, Muller T, Neubert L, Zurbriggen A, Botteron C, Pohle D, Schoon H, Haas L, Jackson AC: Rabies in red foxes (Vulpes vulpes) experimentally infected with European bat lyssavirus type 1. J Vet Med B Infect Dis Vet Public Health 2004; 51: 327-332.
28. Vos A, Muller T, Cox J, Neubert L, Fooks AR: Susceptibility of ferrets (Mustela putorius furo) to experimentally induced rabies with European Bat Lyssaviruses (EBLV). J Vet Med B Infect Dis Vet Public Health 2004; 51: 55-60.
29. Hanlon CA, Kuzmin IV, Blanton JD, Weldon WC, Manangan JS, Rupprecht CE: Efficacy of rabies biologics against new lyssaviruses from Eurasia. Virus Res 2005; 111: 44-54.
30. Perrin P, De Franco M, Gontier-Jallet C, Fouque F, Morgeaux S, Tordo N, Colle JH: Antigen-specific cell-mediated immune response in mice is suppressed by infection with pathogenic Lyssaviruses. Res Virol 1996; 147: 289-299.
31. Thoulouze MI, Lafage M, Montano-Hirose JA, Lafon M: Rabies virus infects mouse and human lymphocytes and induces apoptosis. J Virol 1997; 71: 7372-7380.
32. Fu ZF, Jackson AC: Neuronal dysfunction and death in rabies virus infection. J Neurovirol 2005; 11: 101-106.
33. Kassis R, Larrous F, Estaquier J, Bourhy H: Lyssavirus matrix protein induces apoptosis by a TRAIL-dependent mechanism involving caspase-8 activation. J Virol 2004; 78: 6543-6555.
34. Morimoto K, Hooper DC, Spitsin S, Koprowski H, Dietzschold B: Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J Virol 1999; 73: 510-518.
35. Prehaud C, Lay S, Dietzschold B, Lafon M: Glycoprotein of nonpathogenic rabies viruses is a key determinant of human cell apoptosis. J Virol 2003; 77: 10537-10547.
36. Dietzschold B, Wunner WH, Wiktor TJ, Lopes AD, Lafon M, Smith CL, Koprowski H: Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci USA 1983; 80: 70-74.
37. Tuffereau C, Leblois H, Benejean J, Coulon P, Lafay F, Flamand A: Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice. Virology 1989; 172: 206-212.
38. Coulon P, Ternaux JP, Flamand A, Tuffereau C: An avirulent mutant of rabies virus is unable to infect motoneurons in vivo and in vitro. J Virol 1998; 72: 273-278.
39. Tuffereau, C, Desmézières E, Bénéjean J, Jallet C, Flamand A, Tordo N, Perrin P: Interaction of lyssaviruses with the low-affinity nerve-growth factor receptor p75 NTR. J Gen Virol 2001; 82: 2861-2867.
40. Desmézières E, Maillard A, Gaudin Y, Tordo N, Perrin P: Differential stability and fusion activity of Lyssavirus glycoprotein trimers. Virus Res 2003; 91: 181-187.
41. Pastoret PP, Brochier B: Epidemiology and control of fox rabies in Europe. Vaccine 1999; 17: 1750-1754.
42. Slate D, Rupprecht CE, Rooney JA, Donovan D, Lein DH, Chipman RB: Status of oral rabies vaccination in wild carnivores in the United States. Virus Res 2005; 111: 68-76.
43. Messenger SL, Smith JS, Orciari LA, Yager PA, Rupprecht CE: Emerging pattern of rabies deaths and increased viral infectivity. Emerg Infect Dis 2003; 9: 151-154.
44. Fooks AR, McElhinney LM, Pounder DJ, Finnegan CJ, Mansfield K, Johnson N, Brookes SM, Parsons G, White K, McIntyre PG, Nathwani D: Case report: isolation of a European bat lyssavirus type 2a from a fatal human case of rabies encephalitis. J Med Virol 2003; 71: 281-289.
45. Tordo N: Characteristic and molecular biology of the rabies virus, in Meslin FX, Bögel K (eds): Laboratory Techniques in Rabies: World Health Organization, Geneva, 1996, pp 28-51.
46. Bahloul C, Jacob Y, Tordo N, Perrin P: DNA-based immunisation for exploring the enlargement of immunological cross-reactivity against the lyssaviruses. Vaccine 1998; 16: 417-425.
47. Jallet C, Jacob Y, Bahloul C, Drings A, Desmezières E, Tordo N, Perrin P: Chimeric lyssavirus glycoproteins with increased immunological potential. J Virol 1999; 73: 225-233.
48. Brookes SM, Parsons G, Johnson N, McElhinney LM, Fooks AR. Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses. Vaccine 2005; 23: 4101-4109.
49. Nel LH, Niezgoda M, Hanlon CA, Morril PA, Yager PA, Rupprecht CE: A comparison of DNA vaccines for the rabies-related virus, Mokola. Vaccine 2003; 21: 2598-2606.
50. Perrin P, Jacob Y, Aguilar-Setien A, Loza-Rubio E, Jallet C, Desmezières E, Aubert M, Cliquet F, Tordo N: Immunization of dogs with a DNA vaccine induces protection against rabies virus. Vaccine 2000; 18: 479-486.
51. Desmezières E, Jacob Y, Saron MF, Delpeyroux F, Tordo N, Perrin P: Lyssavirus glycoproteins expressing immunologically potent B cell and cytotoxic T lymphocyte epitopes as prototypes for multivalent vaccines. J Gen Virol 1999; 80: 2343-2351.